These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11387502)

  • 21. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Yoshikawa T; Pardridge WM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
    Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
    Pei Z; Pang SF; Cheung RT
    Stroke; 2003 Mar; 34(3):770-5. PubMed ID: 12624306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotection by sildenafil: neuronal networks potentiation in acute experimental stroke.
    Chen XM; Wang NN; Zhang TY; Wang F; Wu CF; Yang JY
    CNS Neurosci Ther; 2014 Jan; 20(1):40-9. PubMed ID: 24034153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irisin Peptide Protects Brain Against Ischemic Injury Through Reducing Apoptosis and Enhancing BDNF in a Rodent Model of Stroke.
    Asadi Y; Gorjipour F; Behrouzifar S; Vakili A
    Neurochem Res; 2018 Aug; 43(8):1549-1560. PubMed ID: 29882126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-α/TNFR1/NF-кB pathway in transient focal cerebral ischaemia.
    Khaksar S; Bigdeli MR
    Brain Inj; 2017; 31(13-14):1932-1943. PubMed ID: 28872345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat.
    Zhang Y; Feustel PJ; Kimelberg HK
    Brain Res; 2006 Jun; 1094(1):200-6. PubMed ID: 16709402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats.
    Ellsworth JL; Garcia R; Yu J; Kindy MS
    Stroke; 2003 Jun; 34(6):1507-12. PubMed ID: 12738892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.
    Liu XF; Fawcett JR; Thorne RG; DeFor TA; Frey WH
    J Neurol Sci; 2001 Jun; 187(1-2):91-7. PubMed ID: 11440750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
    Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
    Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
    Li Q; Stephenson D
    Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats.
    Lee EJ; Chen HY; Wu TS; Chen TY; Ayoub IA; Maynard KI
    J Neurosci Res; 2002 Jun; 68(5):636-45. PubMed ID: 12111854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice.
    Kilic U; Kilic E; Dietz GP; Bähr M
    Stroke; 2003 May; 34(5):1304-10. PubMed ID: 12677018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
    Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
    Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain protection from stroke with intravenous TNFα decoy receptor-Trojan horse fusion protein.
    Sumbria RK; Boado RJ; Pardridge WM
    J Cereb Blood Flow Metab; 2012 Oct; 32(10):1933-8. PubMed ID: 22714051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yonkenafil: a novel phosphodiesterase type 5 inhibitor induces neuronal network potentiation by a cGMP-dependent Nogo-R axis in acute experimental stroke.
    Chen X; Wang N; Liu Y; Liu Y; Zhang T; Zhu L; Wang Y; Wu C; Yang J
    Exp Neurol; 2014 Nov; 261():267-77. PubMed ID: 25064698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of early and delayed ischemic postconditioning enhances brain-derived neurotrophic factor production by upregulating the ERK-CREB pathway in rats with focal ischemia.
    Wu H; Yang SF; Dai J; Qiu YM; Miao YF; Zhang XH
    Mol Med Rep; 2015 Nov; 12(5):6427-34. PubMed ID: 26398857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection in stroke in the mouse with intravenous erythropoietin-Trojan horse fusion protein.
    Fu A; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    Brain Res; 2011 Jan; 1369():203-7. PubMed ID: 21047502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N2 neutrophils may participate in spontaneous recovery after transient cerebral ischemia by inhibiting ischemic neuron injury in rats.
    Hou Y; Yang D; Xiang R; Wang H; Wang X; Zhang H; Wang P; Zhang Z; Che X; Liu Y; Gao Y; Yu X; Gao X; Zhang W; Yang J; Wu C
    Int Immunopharmacol; 2019 Dec; 77():105970. PubMed ID: 31675618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.